Evidence map›Paper›PMID 37407247›Full record

ArticleBMJ paediatrics open2023

NeuroCNVscore: a tissue-specific framework to prioritise the pathogenicity of CNVs in neurodevelopmental disorders.

Xuanshi Liu, Wenjian Xu, Fei Leng, Peng Zhang, Ruolan Guo, Yue Zhang, Chanjuan Hao, Xin Ni, Wei Li

Open access · diamondAbstract read
In one paragraph

Article in BMJ paediatrics open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xuanshi LiuBeijing Children's Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-8019-0291
Wenjian XuBeijing Children's Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-4304-3479
Fei LengBeijing Children's Hospital, Capital Medical University, Beijing, China.
Peng ZhangBeijing Children's Hospital, Capital Medical University, Beijing, China.
Ruolan GuoBeijing Children's Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-3378-2008
Yue ZhangBeijing Children's Hospital, Capital Medical University, Beijing, China.
Chanjuan HaoBeijing Children's Hospital, Capital Medical University, Beijing, China liwei@bch.com.cn nixin@bch.com.cn hchjhchj@163.com.
Xin NiBeijing Children's Hospital, Capital Medical University, Beijing, China liwei@bch.com.cn nixin@bch.com.cn hchjhchj@163.com.ORCID 0000-0002-7781-2600
Wei LiBeijing Children's Hospital, Capital Medical University, Beijing, China liwei@bch.com.cn nixin@bch.com.cn hchjhchj@163.com.ORCID 0000-0002-0248-5510
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeurodevelopmental disorders (NDDs) are associated with altered development of the brain especially in childhood. Copy number variants (CNVs) play a crucial role in the genetic aetiology of NDDs by disturbing gene expression directly at linear sequence or remotely at three-dimensional genome level in a tissue-specific manner. Despite the substantial increase in NDD studies employing whole-genome sequencing, there is no specific tool for prioritising the pathogenicity of CNVs in the context of NDDs.

methodsUsing an XGBoost classifier, we integrated 189 features that represent genomic sequences, gene information and functional/genomic segments for evaluating genome-wide CNVs in a neuro/brain-specific manner, to develop a new tool, neuroCNVscore. We used Human Phenotype Ontology to construct an independent NDD-related set.

resultsOur neuroCNVscore framework (https://github.com/lxsbch/neuroCNVscore) achieved high predictive performance (precision recall=0.82; area under curve=0.85) and outperformed an existing reference method SVScore. Notably, the predicted pathogenic CNVs showed enrichment in known genes associated with autism.

conclusionsNeuroCNVscore prioritises functional, deleterious and pathogenic CNVs in NDDs at whole genome-wide level, which is important for genetic studies and clinical genomic screening of NDDs as well as for providing novel biological insights into NDDs.

Indexed as

Autistic DisorderNeurodevelopmental DisordersDNA Copy Number VariationsGenomeHumansVirulenceCopy number variantGene expressionNeurodevelopmental disorderPathogenicityTissue specificity

Identifiers

PMID37407247
PMCPMC10335557
OpenAlexW4383215762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.